LEP and obesity disorder: In leptin transgenic TET-ON mice, oral doxycycline (DOX) causes leptin overexpression in proportion to the concentration of DOX, allowing for the transient elevation of leptin without increasing fat mass and consequently avoiding any obesity co-morbidities.